Reading up on Zepbound
2 deep · digging since nov 22, 25
- New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial - The New York Times
A clinical trial of Eli Lilly's retatrutide, which targets three hormones, resulted in significantly greater weight loss than any currently approved drug.
- Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value - The New York Times
Eli Lilly, the drugmaker behind Zepbound and Mounjaro, became the first health-care company to achieve a $1 trillion market value.